Latest News & Features
Biotech
Turnaround for 10x after Federal Circuit setback as Delaware jury finds Qiagen-owned Parse infringed three patents covering single-cell sequencing technology. 3 September 2026
MedTech
A decision at the USPTO has cleared the way for renewed enforcement in the drugmaker’s dispute over light-based dermatology tech. 3 September 2026
Careers
The senior transactions specialist brings experience advising pharmaceutical, biotechnology and technology companies on strategic alliances, licensing, M&A and cross-border transactions. 2 September 2026
Careers
One of the country's most prominent patent judges has joined A&O Shearman after nearly eight years on the federal bench. 2 September 2026
Biotech
Judges dismissed an appeal from MSN Laboratories, which was hoping to show that several patents covering Cabometyx were invalid and would not be infringed by its generic product. 1 September 2026
Careers
Two patent litigators have jumped ship from a boutique to join Pinsent Masons' Düsseldorf office, as the firm aims to strengthen its UPC firepower. 1 September 2026
Biotech
Efforts to shut down an eight-patent dispute over cancer-detection technology have run into a hurdle in a Delaware federal court. 31 August 2026
Europe
This year’s tables provide a guide to the best of the UK market for legal advice on the protection, enforcement and exploitation of patents. 28 August 2026
Pharma
Turkish regulators are investigating the drugmaker over its efforts to protect its drug from generic rivals—conduct that may sound familiar to European competition watchers. 27 August 2026
Regulation & Industry
Dozens of new and revised guidances could make it faster and less costly to bring generics to market, as the US ramps up pressure on drug prices. 27 August 2026